Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
US10612028B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 16, 2017 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Oct 16, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/164
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method of preventing or treating ocular vascular hyperpermeability including macular edema, in a subject comprising inhibiting Sema3A activity. Also disclosed are compositions and their use for preventing or treating Sema3A-dependent ocular vascular hyperpermeability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.